TrialNature medicine2019

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

Thomas Powles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.